Key references: Management of diabetic ketoacidosis in adults
Bonora BM, Avogaro A, Fadini GP. Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: An updated review of the literature. Diabetes Obes Metab 2018;20(1):25–33. https://www.ncbi.nlm.nih.gov/pubmed/28517913
Craig ME, Twigg SM, Donaghue K, Cheung NW, Cameron FJ. National evidence-based clinical care guidelines for type 1 diabetes for children, adolescents and adults. Canberra: Australian Department of Health and Ageing; 2011. www.diabetessociety.com.au/position-statements.asp
Diabetes Canada Clinical Practice Guidelines Expert Committee. Goguen J, Gilbert J. Hyperglycemic emergencies in adults. Can J Diabetes 2018;42 Suppl 1:S109–S14. https://www.ncbi.nlm.nih.gov/pubmed/29650082
Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009;32(7):1335–43. https://www.ncbi.nlm.nih.gov/pubmed/19564476
Meyer EJ, Gabb G, Jesudason D. SGLT2 inhibitor-associated euglycemic diabetic ketoacidosis: A South Australian clinical case series and Australian spontaneous adverse event notifications. Diabetes Care 2018;41(4):e47–e9. https://www.ncbi.nlm.nih.gov/pubmed/29440112
Tran TTT, Pease A, Wood AJ, Zajac JD, Martensson J, Bellomo R, et al. Review of evidence for adult diabetic ketoacidosis management protocols. Front Endocrinol (Lausanne) 2017;8:106. https://www.ncbi.nlm.nih.gov/pubmed/28659865
Venkatesh B, Pilcher D, Prins J, Bellomo R, Morgan TJ, Bailey M. Incidence and outcome of adults with diabetic ketoacidosis admitted to ICUs in Australia and New Zealand. Crit Care 2015;19:451. https://www.ncbi.nlm.nih.gov/pubmed/26715333
